{
    "nct_id": "NCT03289195",
    "official_title": "A Prospective Study To Evaluate The Accuracy Of Percutaneous Breast MRI Biopsy In Diagnosing A Pathologic Complete Response Following Neoadjuvant Chemotherapy",
    "inclusion_criteria": "* Women age 18 years or older\n* Confirmed histologic diagnosis of operable HER2 overexpressing (ER<10%, PR<10%, and HER2 2+ or FISH amplified) OR triple negative (ER<10%, PR<10%, and HER2 0/1+ or 2+/FISH not amplified) OR ER positive invasive ductal or invasive lobular breast cancer including MSKCC pathology confirmation\n* Operable breast cancer treated with NAC undergoing either breast conservation or total Mastectomy who have had a post-NAC clinical bilateral breast MRI demonstrating a complete imaging response, which is defined as no residual tumor enhancement.\n* No indication of distant metastases (M0)\n* Tumor site amenable to MRI guided biopsy as determined by the radiologist\n* Definitive surgery being performed at MSKCC within within 0-60 days of completing NAC\n* ECOG performance status score of 0 to â‰¤ 2 and or KPS performance status score of 80% to 100%\n* Women of childbearing potential (WOCBP) must not be pregnant.\n* Women must not be breastfeeding\n* Willing and able to provide informed consent and adhere to the study visit schedule and plan as specified in this protocol\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Medical history and concurrent disease:\n\n  * Prior history of treated breast cancer\n  * Any underlying medical or psychiatric conditions, which in the opinion of the investigator, will make performing the study intervention hazardous or obscure the interpretation of the results\n* Prohibited Treatments and/or Therapies:\n\n  * Prior history of breast cancer surgery and/or radiotherapy.",
    "miscellaneous_criteria": ""
}